ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

June 20, 2014

$20 Million In Construction Funds Approved

April 2, 1976

Fischinger Names Research VP at MUSC (Charleston); Meyskens Names Director Of New UC (Irvine Center)

October 28, 1988

ASCO Supports Tobacco Tax Increase

March 7, 2003

Funding Opportunities.

May 24, 2002

Chemotherapy Patients Can Benefit From Heart Failure Treatment, Study Finds

October 25, 2002